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In the United States and in other industrial-
ized nations, there appears to be an increase in 
the reported incidence of male genito  urinary 
(GU) conditions such as cryp  torchidism 
and hypospadias (Toppari et al. 2001). One 
hypothesis implicates in utero exposure to 
endocrine-disrupting chemicals, environmen-
tal contaminants that mimic or antagonize 
endogenous hormonal activity (Bay et al. 
2006; Birnbaum and Cohen Hubal 2006; 
Sharpe 2006). Animal data strongly support 
the biological plausibility of this hypothesis 
(Bay et al. 2006; Sharpe 2006).
The Michigan Long-Term PBB Study 
provides an opportunity to prospectively 
assess the effects of human exposure to 
polybrominated biphenyl (PBB), a bromi-
nated flame retardant and suspected endo-
crine disruptor. In 1973–1974, Michigan 
residents were exposed to substantial PBB 
levels through contaminated animal and dairy 
products when NutriMaster, a nutritional 
cattle feed supplement, was inadvertently 
replaced with FireMaster, a brominated flame 
retardant (both from Michigan Chemical 
Corp., St. Louis, MI). Beginning in 1976, the 
Michigan Department of Community Health 
(MDCH) enrolled approximately 4,000 indi-
viduals with a range of exposure levels into a 
cohort study for long-term health monitoring 
(Fries 1985). This cohort of exposed indi-
viduals and their offspring (who were sub-
sequently enrolled into the cohort) have been 
followed through the present time.
In the United States, PBB production 
ceased in 1979. However, concern remains for 
long-term health effects given continued pro-
duction of structurally related organohalogen 
flame retardants [Agency for Toxic Substances 
and Disease Registry (ATSDR) 2004; Juhasz 
et al. 2007]. PBBs and similar organo  halogens 
are stable, persistent pollutants possessing 
extremely long half-lives, with estimates rang-
ing from 11 to 28 years, depending on the 
initial level of exposure (Blanck et al. 2000a; 
Rosen et al. 1995). Furthermore, PBBs are 
transferred across the placenta, and the fetus 
may be exposed in utero (Eyster et al. 1983; 
Jacobson et al. 1984). Prior investigations of 
in utero exposure to other organohalogens and 
the risk for GU conditions in boys are limited 
by case–control designs, with mixed results 
(Bhatia et al. 2005; Damgaard et al. 2006; 
Hosie et al. 2000; Longnecker et al. 2002). In 
a prospective study, Main et al. (2007) found 
that the content of polybrominated diphe-
nyl ethers in maternal breast milk was higher 
among boys with cryptorchidism compared 
with boys without this condition. Similarly, 
Brucker-Davis (2008) found an association 
between cryptorchidism and polychlorinated 
biphenyls (PCBs).
The FireMaster mixture of PBBs may 
include congeners with estrogenic, anti-
estrogenic, or anti  androgenic activity 
(McCormack et al. 1979; Nakari and Pessala 
2005; Newton et al. 1982). Because of the 
possibility of varied effects, we began our 
study with a general exploratory hypothesis, 
that PBB exposure may affect a variety of GU 
conditions.
We previously found evidence of trans-
generational endocrine effects of PBBs among 
female cohort members (Blanck et al. 2000b). 
We designed the present study to examine 
transgenerational endocrine effects among 
male cohort members. Specifically, we inves-
tigated in utero PBB exposure and reported 
GU conditions among the male offspring of 
cohort members.
Materials and Methods
Population. The institutional review boards at 
MDCH and at Emory University approved 
the study. The study population, drawn 
from the Michigan Long-Term PBB Study, 
included male offspring of female cohort 
members. Female cohort members were poten-
tially exposed to PBB between the time when 
contaminated feed was delivered to Michigan 
farms (~ May 1973) and the time at which the 
farms were quarantined (~ May 1974). Because 
of the long half-life of PBB, these females 
maintained a body burden decades later and 
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Ba c k g r o u n d: The upward trend in industrial nations in the incidence of male genitourinary (GU) 
conditions may be attributed to increased exposure to endocrine disruptors. Polybrominated biphenyl 
(PBB), a brominated flame retardant, is one such suspected endocrine disruptor. 
oB j e c t i v e: We investigated the relationship between maternal serum levels of PBBs and GU condi-
tions among male offspring exposed in utero.
Me t h o d s : In this cohort study of sons born to women accidentally exposed to PBBs during 
1973–1974, we examined self-reported data on GU conditions among male offspring in relation 
to maternal serum PBB levels. We used generalized estimating equations to calculate odds ratios 
(ORs), controlling for gestational age at birth.
re s u l t s: Of 464 sons, 33 reported any GU condition (13 hernias, 10 hydroceles, 9 cryptorchidism, 
5 hypospadias, and 1 varicocele). Four reported both hernia and hydrocele, and one both hernia 
and cryptorchidism. After adjustment for gestational age at birth, sons of highly exposed women 
(> 5 ppb) were twice as likely to report any GU condition compared with sons of the least exposed 
women [≤ 1 ppb; OR = 2.0; 95% confidence interval (CI), 0.8–5.1]. This risk was increased when 
we excluded sons born after the exposure but before the mother’s serum PBB meas  ure  ment (OR 
= 3.1; 95% CI, 1.0–9.1). We found evidence of a 3-fold increase in reported hernia or hydrocele 
among sons with higher PBB exposure (test of trend p-value = 0.04). Neither hypospadias nor cryp-
torchidism was individually associated with PBB exposure.
co n c l u s i o n s: Although cryptorchidism and hypospadias were not associated with in utero PBB 
exposure, this study suggests that other GU conditions may be associated with exposure to endocrine-
disrupting chemicals during development.
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exposed subsequent pregnancies to PBB. 
Thus, we included in the study sons born after 
1 July 1973 who had potential in utero PBB 
exposure. Participants gave either informed 
consent or assent.
PBB exposure assessment. Maternal 
serum PBB levels were measured at the time 
in which the mother enrolled in the cohort 
using gas chromatography with electron- 
capture detection. PBB quantitation was 
based on PBB-153, the main congener 
involved in the PBB incident (Fries 1985). 
The limit of detection (LOD) for serum PBB 
was 1 ppb. Samples were collected from non-
fasting participants, and serum lipid levels 
were not available.
We estimated a mother’s serum PBB level 
at the time of her son’s conception using a 
PBB decay model and used this estimation as a 
surrogate for her son’s in utero PBB exposure. 
Briefly, the decay model included body mass 
index (BMI) at initial PBB measurement, par-
ity, age, smoking status, and breast-feeding. 
The decay model was validated using a sub-
set of samples. The correlation between the 
predicted and observed concentrations was 
r = 0.93 (Terrell et al. 2008). The estimated 
date of conception was calculated by subtract-
ing the gestational age from the date of birth. 
Although all mothers were exposed to PBB 
before the birth of their sons, not all mothers 
had their PBB measured before the birth of 
their sons. For most sons (n = 393), maternal 
PBB was meas  ured before conception, per-
mitting a prospective extrapolation of esti-
mated maternal exposure at the time of the 
son’s conception. The estimated conception 
date for 71 sons, however, was after the expo-
sure period start (1 July 1973) but before the 
mother’s blood was drawn for PBB measure-
ment. In these cases, we used the PBB decay 
model to extrapolate backward to estimate 
maternal PBB at conception.
Questionnaires. We assessed reporting 
of GU conditions among participants via 
a parent–son questionnaire sent to parents 
of sons 5–18 years of age and via telephone 
interview for adult sons (≥ 18 years). In the 
parent–son questionnaire, participants were 
asked specifi  cally whether they had ever been 
told by a health care professional that they 
had varicocele/varicose veins in the scrotum, 
cryptorchidism/undescended testes, or hypo-
spadias/abnormally placed urethral opening. 
In addition, the questionnaire included an 
open-ended question allowing individuals to 
report “any other conditions of the genitals or 
reproductive system.” Three age-specific ver-
sions contained minor wording differences. In 
the telephone interview, adult sons were asked 
whether they had ever been told by a health 
care professional that they had varicocele/ 
varicose veins of the scrotum, undescended 
testes, or hypospadias. The telephone inter-
view also included an open-ended question 
allowing adult sons to report “any other birth 
defect of the genital area.”
Questionnaires were sent to 375 sons 
5–18 years of age with maternal PBB meas-
ure  ments, and 248 were completed (66%). 
Parents completed questionnaires for sons 
5–10 years of age (n = 84). Parents and/or sons 
completed questionnaires for sons 11–16 years 
of age (n = 155). Sons 17 years of age (n = 9) 
completed questionnaires themselves.
Of the 363 adult sons we attempted to 
contact for telephone interview, 42 could not 
be located, 1 was deceased, and 75 with pre-
sumably correct contact information could 
not be reached. Of 245 contacted, 216 com-
pleted the telephone interview (88% contact 
response rate).
We obtained gestational age at the time 
of birth from birth certificates (66%). When 
birth certificates were not available, gestational 
age was determined from medical records 
(18%). If a medical record was not available, 
we obtained gestational age from a maternal 
telephone interview (15%). Similarly, birth 
weight was obtained from birth certificates 
(87%), a medi  cal record (4%), or the PBB 
cohort infant enrollment form (8%).
Statistical analysis. Data from parent–
son questionnaires and telephone interviews 
were combined for analyses. Varicocele/vari-
cose veins in the scrotum, cryptorchidism/
undescended testes, and hypospadias/abnor-
mally placed urethral opening were specifically 
addressed by the questionnaire and inter-
view, and were included in the analyses. We 
included responses to “any other conditions 
(or birth defect) of the genitals or reproductive 
system” if determined to be a GU condition 
by physician reviewers (C.D. and J.J.D.).
We used both maternal enrollment PBB 
levels and estimated maternal levels at concep-
tion as surrogates for the son’s in utero expo-
sure. PBB concentrations were cate  gorized into 
three groups based on maternal enrollment 
levels: the LOD (≤ 1 ppb) and the median of 
detectable values among individuals reporting 
any GU condition (1–5 ppb, > 5 ppb). We 
calculated the frequency of each GU condition 
stratified by maternal PBB level.
We used generalized estimating equations 
(GEEs) to account for relatedness of brothers 
Table 1. Characteristics of males 5–18 years of age stratified by maternal serum PBB concentrationa at the 
time of enrollment into the cohort (n = 248).
  Maternal PBB concentration [n (%)]
Characteristic  No. (%)  ≤ LOD  1–3 ppb  >3 ppb  p-Valueb
Age (years)          0.27
  5–10   84 (33.9)  21 (30.4)  26 (28.9)  37 (41.6)
  11–13   67 (27.0)  16 (23.2)  26 (28.9)  25 (28.1)
  14–16  66 (26.6)  19 (27.5)  28 (31.1)  19 (21.4)
  17–18  31 (12.5)  13 (18.8)  10 (11.1)  8 (9.0)
Gestational age (weeks)          0.15
  34–37  29 (11.7)  9 (13.0)  8 (8.9)  12 (13.5)
  38–42  215 (86.7)  60 (87.0)  78 (86.7)  77 (86.5)
  43–45  4 (1.6)  0  4 (4.4)  0
Birth weight (g)          0.56
  964–2,499  5 (2.0)  1 (1.5)  2 (2.2)  2 (2.3)
  2,500–4,500  208 (83.9)  62 (89.9)  76 (84.4)  70 (78.7)
  4,501–5,216  10 (4.0)  2 (2.9)  2 (2.2)  6 (6.7)
  Missing  25 (10.1)  4 (5.8)  10 (11.1)  11 (12.4)
aPBB categorized as ≤ LOD (1.0 ppb), > LOD to the median of detectable maternal values among participants (1–3 ppb), 
and above the median (> 3 ppb). bFisher’s exact p-value. 
Table 2. Characteristics of males 18–31 years of age stratified by maternal PBB serum concentrationa at 
the time of enrollment into the cohort (n = 216).
  Maternal PBB concentration [n (%)]
Characteristic  No. (%)  ≤ LOD  1–3.5 ppb   > 3.5 ppb  p-Value
Age (years)          0.78b
  18–19   30 (13.9)  11 (14.3)  8 (11.4)  11 (15.9)
  20–24   98 (45.4)  34 (44.2)  37 (52.9)  27 (39.1)
  25–29   74 (34.3)  27 (35.1)  22 (31.4)  25 (36.2)
  30–31   14 (6.5)  5 (6.5)  3 (4.3)  6 (8.7)
Gestational age (weeks)          0.63
  34–37  22 (10.2)  11 (14.3)  6 (8.6)  5 (7.3)
  38–42  173 (80.1)  59 (76.6)  56 (80.0)  58 (84.1)
  43–45  21 (9.7)  7 (9.1)  8 (11.4)  6 (8.7)
Birth weight (g)          0.36b
  1,928–2,499  7 (3.3)  1 (1.3)  1 (1.5)  5 (7.3)
  2,500–4,500  196 (91.2)  71 (92.2)  64 (92.8)  61 (88.4)
  4,501–5,868  12 (5.6)  5 (6.5)  4 (5.8)  3 (4.4)
aPBB categorized as ≤ LOD of 1.0 ppb, > LOD to the median of detectable maternal values among participants (3.5 ppb), 
and above the median (> 3.5 ppb). bFisher’s exact p-value; chi-square p-value is the default.Brominated flame retardant and genitourinary conditions
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and adjusted for gestational age, and we calcu-
lated odds ratios (ORs) and 95% confidence 
intervals (CIs). We modeled the odds of 
developing any GU condition among all sons 
and compared these estimates with models 
excluding the 71 sons who were born after 
the exposure period but before their mothers’ 
PBB levels were measured. In addition, we 
modeled the odds of developing related GU 
conditions (cryptorchidism/hypospadias and 
hernia/hydrocele).
We examined confounding by gestational 
age, birth weight, and maternal age at concep-
tion. We did not assess confounding by race 
because 99% of the mothers in this cohort 
are Caucasian. We had limited information 
on smoking during pregnancy (only sons 
> 18 years of age were asked to respond to this 
question), so we were unable to assess con-
founding by maternal smoking during preg-
nancy. Calculations were performed using SAS, 
version 9.1 (SAS Institute Inc., Cary, NC).
Results
Estimated maternal PBB at conception for 
younger sons who participated by parent–
son questionnaire (mean = 10.9 ppb; range, 
≤ LOD to 361 ppb) was lower than that of 
older sons who participated by telephone 
interview (mean = 13.1; range, ≤ LOD to 
403 ppb); the median detectable maternal 
PBB level was 3.0 ppb among younger sons 
and 3.5 ppb among older sons.
The distribution of PBB concentrations did 
not differ between participants and nonpartici-
pants. Tables 1 and 2 show charac  teris  tics of 
sons participating in the parent–son question-
naire and telephone interview, respectively. 
Neither gestational age (range, 34–45 weeks) 
nor birth weight (range, 964–5,868 g) differed 
by PBB level.
Of the 464 sons, 33 reported any GU con-
dition, including 13 hernias, 10 hydro  celes, 
9 cases of cryptorchidism, 5 hypo  spadias, and 
1 varicocele. Four individuals reported both 
hernia and hydrocele, and one reported both 
hernia and cryptorchidism. The incidences 
of GU conditions within the PBB long-term 
study were cryp  tor  chidism (~ 19 in 1,000), 
hernia (~ 28 in 1,000), hydro  cele (~ 22 in 
1,000), and hypospadias (~ 11 in 1,000).
Table 3 shows the frequency of GU 
conditions stratified by maternal PBB level 
at enrollment and participant age; 7.7% of 
sons 5–18 years of age and 5.6% of sons 
18–30 years of age reported any GU condition. 
Individuals with the highest maternal enroll-
ment PBB levels (> 5 ppb) were more likely to 
report any GU condition than those with the 
lowest maternal levels (10.2% vs. 5.5%).
When we included all sons in the analy-
sis, there was a nonsignificant 2-fold increase 
in the odds of GU conditions among sons in 
the highest PBB exposure group (for maternal 
enrollment PBB: OR = 2.0; 95% CI, 0.8–5.1; 
for estimated maternal PBB at conception: 
OR = 1.6; 95% CI, 0.6–4.3; Table 4). The 
effect of gestational age was in the expected 
direction. Sons born at ≤ 37 weeks of gestation 
were more likely to report a GU condition 
(OR = 2.6; 95% CI, 1.0–6.7). Adjusting for 
birth weight, gestational age, or maternal age at 
conception did not substantially alter the ORs 
for PBB exposure.
In models excluding the 71 sons who were 
born after the exposure period but before their 
mothers’ PBB was measured (Table 4), males 
with PBB exposure > 5 ppb were three times 
as likely to report any GU condition compared 
with those with the lowest exposure (≤ 1 ppb; 
for maternal enrollment PBB: OR = 3.1; 95% 
CI, 1.0–9.1; for estimated maternal PBB at 
conception: OR = 2.68; 95% CI, 0.9–7.9). 
Sons with a maternal enrollment PBB of 
1–5 ppb were at slightly increased risk that did 
not reach statistical significance (for maternal 
enrollment PBB: OR = 2.1; 95% CI, 0.7–6.3; 
for estimated maternal PBB at conception; OR 
= 1.6; 95% CI, 0.6–4.4).
When grouped together, cryptorchidism 
and hypo  spadias did not show an associa-
tion with PBB exposure (OR = 0.7; 95% CI 
0.1–3.8 for the highest exposed compared 
Table 3. Frequencies [n (%)] of self-reported GU conditions in sons, stratified by age and maternal PBB serum concentrationa at the time of enrollment into the 
cohort (n = 464).
  All sons (5–30 years of age) (n = 464)  Sons 5–18 years of age (n = 248)  Sons 18–30 years of age (n = 216)
  ≤ LOD  1–5.0 ppb  > 5.0 ppb  p-Value  ≤ LOD  1–5.0 ppb  > 5.0 ppb  p-Value  ≤ LOD  1–5.0 ppb  > 5.0 ppb  p-Value
Any GU condition
  Yes  8 (5.5)  14 (6.6)  11 (10.2)  0.11b  4 (5.8)  12 (10.3)  5 (7.9)  0.55b  4 (5.2)  2 (2.1)  6 (13.6)  0.03
  No  138 (94.5)  197 (93.4)  96 (89.7)    65 (94.2)  104 (89.7)  58 (92.1)    73 (94.8)  93 (97.9)  38 (86.4)
Hernia
  Yes  2 (1.4)  3 (1.4)  8 (7.5)  0.01  0  3 (2.6)  3 (4.8)  0.14  2 (2.6)  0  5 (11.4)  0.002
  No  144 (98.6)  208 (98.6)  99 (92.5)    69 (100)  113 (97.4)  60 (95.2)    75 (97.4)  95 (100)   39 (88.6)
Hydrocele
  Yes  2 (1.4)  5 (2.4)  3 (2.8)  0.78  1 (1.5)  5 (4.3)  2 (3.2)  0.59  1 (1.3)  0  1 (2.3)  0.31
  No  144 (98.6)  206 (97.6)  104 (97.2)    68 (98.5)  111 (95.7)  61 (96.8)    76 (98.7)  95 (100)  43 (97.7)
Cryptorchidism
  Yes  3 (2.1)  5 (2.4)  1 (0.9)  0.83  3 (4.5)  3 (2.6)  1 (1.6)  0.70  0  2 (2.1)  0  0.69
  No  141 (97.9)  204 (97.6)  105 (99.1)    64 (95.5)  111 (97.4)  61 (98.4)    77 (100)  93 (97.9)  44 (100)
Hypospadias
  Yes  1 (0.7)  3 (1.4)  1 (0.9)  0.86  0  3 (2.6)  1 (1.6)  0.59  1 (1.3)  0  0  0.56
  No  143 (99.3)  205 (98.6)  106 (99.1)    67 (100)  111 (97.4)  62 (98.4)    76 (98.7)  94 (100)  44 (100)
Varicocele
  Yes  0  0  1 (0.9)  0.23  0  0  0    0  0  1 (2.3)  0.20
  No  144 (100)  209 (100)  106 (99.1)    67 (100)  114 (100)  63 (100)    77 (100)  95 (100)  43 (97.7)
aPBB categorized as ≤ LOD (1.0 ppb), > LOD to the median of maternal detectable PBB concentrations among cases (5 ppb), and greater than the median (> 5 ppb). bChi square p-value; 
Fisher’s exact p-values are the default.
Table 4. Adjusted ORs and 95% CIs for self-reported GU conditions.a
  Maternal enrollment PBB  Estimated maternal PBB at conception
Condition  ≤ LOD  1–5.0 ppb  > 5.0 ppb  Trend p-value  ≤ LOD  1–5.0 ppb  > 5.0 ppb  Trend p-value
Any GU (n = 464)b   Reference  1.4 (0.5–3.5)  2.0 (0.78–5.1)  0.50  Reference  1.1 (0.4––2.5)  1.6 (0.6–4.3)  0.35
Any GU (n = 393)c   Reference  2.1 (0.7–6.3)  3.1 (1.0–9.1)  0.17  Reference  1.64 (0.6–4.4)  3.63 (0.9–7.9)  0.08
Cryptorchidism or hypospadias (n = 393)c  Reference  1.28 (0.4–4.7)  0.71 (0.1–3.8)  0.76  Reference  1.4 (0.4–4.8)  0.5 (0.1–4.7)  0.75
Hernia or hydrocele (n = 393)c  Reference  3.13 (0.4–23.9)  6.16 (0.9–42.5)  0.04  Reference  1.4 (0.3––6.0)  3.7 (0.9–16.0)  0.09
aAdjusted GEE models control for gestational age and the relatedness of siblings; the 5.0 ppb cut-point is the median level among the cases with detectable PBB. b”Any GU” includes 
hernia, hydrocele, cryptorchidism, hypospadias, and varicocele. cExcluding 71 sons who were born after the exposure period but before the mothers’ initial serum PBB measurements.Small et al.
1178  v o l u m e  117 | n u m b e r 7 | July 2009  •  Environmental Health Perspectives
with the least exposed). However, we found 
a 3-fold increase in reporting hydrocele or 
hernia among more highly exposed (p-value 
for trend = 0.04).
Of the individual conditions, only hernia 
appeared statistically associated with PBB expo-
sure (Table 3). Among sons with the highest 
PBB exposure, 7.5% reported hernia compared 
with 1.4% in the lowest exposure group.
Discussion
Our study suggests a possible association 
between reporting one or more GU condi-
tions and in utero PBB exposure that should 
be replicated elsewhere. Boys born to mothers 
with high serum PBB levels were more than 
twice as likely to report any GU conditions. 
Interestingly, the association between PBB 
and hernia and hydrocele—conditions not 
often associated with endocrine disruption—
drove this trend. To our knowledge, this is the 
first study demon  strating such an association 
for PBBs.
The overall incidence of GU conditions in 
the present study was comparable to expected 
rates in the general population. Specifically, 
cryptorchidism (~ 19 in 1,000) was com-
parable to estimates in the general popula-
tion from cohort studies (~ 10–30 in 1,000) 
(Toppari et al. 2001). The incidence of hypo-
spadias in the cohort (~ 11 in 1,000) is simi-
lar to current estimates that reflect an increase 
in the last few decades (2–8 in 1,000; Akre 
et al. 2008; Toppari et al. 2001). The overall 
incidence of hernia (~ 28 in 1,000) and of 
hydrocele (~ 22 in 1,000) was comparable to 
the estimated incidence for congenital hernia 
among U.S. live births (~ 10–20 in 1,000) 
(Davenport 1996).
We included all GU conditions reported 
by questionnaire or telephone interview regard-
less of a priori expectations regarding whether 
in utero PBB exposure would be a pre  disposing 
factor. Cryptorchidism and hypo  spadias, 
which result, respectively, from abnormalities 
in testicular descent (Hutson et al. 1997) and 
penile formation (Baskin and Ebbers 2006), 
are expected to be susceptible to in utero endo-
crine disruption. Hernia and hydrocele are also 
expected to be potentially susceptible to hor-
monal disruption related to failed testicu  lar 
descent and cryp  torchidism. Specifically, her-
nia and/or hydro  cele occur when the processus 
vaginalis fails to close during normal testicular 
descent. This process is believed to be androgen 
dependent (Tanyel 2004). It is unexpected that 
we found no association between PBB expo-
sure and either cryptorchidism or hypospadias.
We included varicocele despite a paucity 
of evidence regarding congenital risk factors. 
Inclusion of conditions neutral to the influ-
ence of endocrine disruptor exposures ought 
to bias toward the null. Interestingly, these 
conditions were reported only among sons 
in the highest exposure group. This may rep-
resent diagnostic bias among sons seeking 
care for other conditions. However, in the 
present study, varicocele was reported inde-
pendently of other GU conditions, suggesting 
that endocrine disruptors may predispose to 
a wider variety of conditions than currently 
acknowledged.
Our finding of increased reports of hernia 
or hydro  cele among the most exposed may be 
explained by an anti  androgenic effect of PBB. 
Animal data suggests anti  androgenic effects 
of peri  natal PBB exposure through increased 
metabolism of testosterone and decreased 
responsiveness to testosterone (McCormack 
et al. 1979; Newton et al. 1982). The poly-
chlorinated biphenyl (PCB) congener 
PCB-138 has demonstrated evidence of anti-
androgenic activity (Bonefeld-Jorgensen et al. 
2001), raising suspicion for anti  androgenic 
activity of PBB-138 (which accounts for 
5–12% of the FireMaster mixture (Hass et al. 
1978). It is plausible that PBBs exert indirect 
effects upon sex hormone activity through 
the inhibition or induction of CYP19 (aro-
matase) responsible for the conversion of 
androgens to estrogens [shown for the struc-
turally similar compounds polybrominated 
diphenyl ethers by Canton et al. (2005)]. It is 
unlikely that the increase in hernia/hydrocele 
could be explained by the estrogenic activ-
ity of PBB-153 (Nakari and Pessala 2005) 
because we did not see an increased risk of 
cryp  torchidism or hypo  spadias. Alternatively, 
the fact that we found increased incidence 
of hernia and hydro  cele without an increase 
in cryp  tor  chidism or hypo  spadias may indi-
cate that the cause of this increase is through 
a route that is not hormonally mediated. 
PBBs and other organo  halogens also inter-
act with non  sex hormone receptors (e.g., the 
aryl hydrocarbon receptor) as well as induce 
cytochrome P450 (CYP) enzymes (ATSDR 
2004). Thus, our findings might be explained 
by anti  androgenic activity of PBB-138 or 
other more complex mechanisms.
A major strength of the present study 
was its prospective design; women who were 
exposed to PBBs from 1973 to 1974 sub-
sequently exposed sons in utero. Interestingly, 
the association between PBB and GU condi-
tions was stronger among the 393 sons with 
whom we estimated PBB forward to the time 
of conception using a decay model. When the 
same model was used to backward extrapolate 
PBB at conception for an additional 71 sons, 
the effect of PBB on risk of GU conditions was 
attenuated. This difference either resulted from 
chance or may suggest backward extrapolation 
of estimated maternal PBB levels at conception 
is less accurate than forward predictions.
Furthermore, maternal PBB at enroll-
ment showed a stronger relationship with GU 
conditions than estimated maternal PBB at 
conception. However, wide CIs indicate that 
there may be no real difference in these esti-
mates, consistent with the long half-life of 
PBB. Like other studies, our assessment of 
in utero exposure was only indirect. Ethical 
and logistical limitations prevent more direct 
measurements.
Age at diagnosis was not available for many 
of the reported conditions. Cryptorchidism 
and hypo  spadias, however, are always con-
genital. The descriptions of reported cases of 
hernia/hydrocele were most consistent with 
congenital forms of these disorders. Twelve 
individuals reporting a hernia/hydrocele 
included comments that indicated the con-
ditions were diagnosed (or surgery was per-
formed) before 5 years of age. However, one 
individual reported surgery at age 17. Of the 
remaining eight cases of hernia/hydrocele, all 
were interviewed between 5 and 15 years of 
age; therefore, the hernia/hydrocele would 
have been diagnosed before 15 years of age. 
The one case of varicocele reported an age at 
diagnosis of 17 years of age.
Nine individuals were born before April 
1974 (9 months after July 1973) and may not 
have been exposed throughout their entire 
gestational period. None of these reported 
GU conditions. If these individuals biased 
our data, it would be toward the null if they 
did not have the opportunity for exposure. 
Because testicular descent occurs at the end of 
pregnancy, we did not want to exclude these 
individuals who were exposed during the later 
part of their gestation from our analyses.
Our study was limited by the use of self-
reported data. The fewer cases of cryp  tor-
chidism reported by the 18- to 30-year-olds 
may be explained by the fact that these condi-
tions were corrected (spontaneously or medi-
cally) during the first year of life and the older 
sons had no knowledge of this. In addition, 
cases of GU conditions may be under  reported 
if only the more severe forms of the dis  order 
were recalled. GU conditions may have been 
misclassified if, for example, a history of 
orchidopexy, which often includes ligation 
of a hernial sac, was recalled as a history of 
hernia and not as cryp  tor  chidism. The effect 
of this mis  classification should be minimal 
in our analysis of “any” reported GU condi-
tion. Among the 33 sons reporting any GU 
condition, 15 consented to a review of medi-
cal records. Of these, we received 13 records. 
Three contained insufficient information 
to confirm or refute the reported diagnosis. 
In the remaining 10 records, we confirmed 
the reported diagnoses. Finally, we cannot 
exclude reporting bias such that mothers and 
sons may be more inclined to remember and 
report a GU condition if they had a high PBB 
exposure. All participants in the PBB long-
term study were informed of their serum PBB 
level shortly after enrollment.Brominated flame retardant and genitourinary conditions
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Compared with prior studies, we were 
able to isolate the effects of a relatively homo-
geneous endocrine disruptor for which the 
precise exposure is known. However, we can-
not exclude the possibility that multiple PBB 
congeners played a role or that other endo-
crine disruptors interacted with PBBs to result 
in the observed associations.
The increasing occurrence of male GU 
anomalies in industrialized countries warrants 
further study to guide public health efforts. In 
the present study, in utero PBB exposure was 
associated with reports of hernia and hydro-
cele. This suggests that endocrine disruptors 
may predispose to a wider variety of conditions 
than currently acknowledged.
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